A New Way to Protect Brain Cells — By Taking the Brakes Off the Cell's Cleanup Crew
Our cells have a cleanup crew. Special enzymes tag worn-out or harmful proteins for disposal, keeping the cell healthy. In many brain diseases, harmful proteins build up faster than the crew can clear them — and researchers at the University of California, Berkeley may have found a new way to help the crew work better.
The study, published in the journal Science on 4 November 2026, describes a new approach to treating complex neurodegenerative diseases. Instead of designing a drug that attacks one harmful protein at a time, the team looked for a way to switch on the cell's own disposal system more strongly.
The brakes on the cleanup crew
The disposal system works through enzymes called E3 ligases. Their job is to tag disease-causing proteins so the cell can break them down. But these enzymes are held back by another set of proteins, called BEX proteins, which act like brakes on the system.
The Berkeley team searched for a small molecule that could push the BEX proteins aside — releasing the brakes while keeping the E3 enzymes able to recognise their normal targets. They screened roughly 120,000 compounds and found two molecules that could do it, called BEX displacer 1 (BD1) and BEX displacer 2 (BD2).
When BD2 displaced the BEX proteins, the E3 enzymes got to work: the breakdown of several of their natural targets increased, more healthy protein was delivered into the mitochondria — the cell's powerhouses — and mitochondrial respiration improved.
Tested on lab-grown neurons
The researchers then tested the approach in cellular models of two rare conditions: COX deficiency syndrome, a rare genetic metabolic disorder, and Friedreich's ataxia, an inherited disorder that causes progressive damage to the nervous system and impairs muscle coordination and balance.
In the COX deficiency tests, BD2 restored respiratory function and protected lab-grown neurons from premature death. It also protected neurons modelling Friedreich's ataxia.
This is early-stage work, and it matters to say so plainly. The results come from lab tests on cells, not from patients, and BD2 is a research molecule, not a medicine. But the idea behind it is a genuinely new one: rather than blocking a harmful protein, take the brakes off the system that clears harmful proteins away. The team describes it as a strategy that could, in time, be applied to other diseases where proteins build up and damage cells.
Why this matters for young scientists
For students, this is a good example of how science moves forward by asking a different question. Instead of "how do we block this one protein?", the team asked "what is stopping the cell from clearing it itself?" That change of angle — from blocking to unblocking — is a pattern worth remembering in biology, and in problem-solving generally.
If your child is curious about how cells work, or about the biology behind brain diseases, a first lesson in biology can start with the cell's cleanup crew and end with why scientists screen 120,000 compounds to find two that work. Book your first lesson
Sources:
- Medical Xpress, "New drug-development strategy might protect neurons by displacing proteins that inhibit helpful enzymes", 4 November 2026: https://medicalxpress.com/news/2026-11-drug-strategy-neurons-displacing-proteins.html
- Srividya Chandrasekhar et al., "Stimulated protein degradation to promote mitochondrial function and neuronal survival", Science (2026). DOI: 10.1126/science.aed2525
London Tutors — post your tutoring request and we will match you with a verified tutor.